{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:15:26Z","timestamp":1765527326504,"version":"3.48.0"},"reference-count":5,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2020-0080_abs_001_w2aab3b7c51b1b6b1aab1c16b1Aa\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe a rare association of two endocrine tumours in a clinical case.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2020-0080_abs_003_w2aab3b7c51b1b6b1aab1c16b2Aa\">\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 54-year-old woman with a classic Papillary thyroid cancer (PTC) assessed by the Endocrinology Department of a tertiary hospital from May-2015 to May-2020. PTC was treated with a total thyroidectomy and lymphadenectomy in May-2015. Initial staging (AJCC\/TNM 7th edition): T3N1bMx. Additionally, two ablative doses of 150\u00a0mCi of 131-I (RAI) were administered until September-2016. No pathological uptake was found on the post-RAI whole-body scan at any level. Due to a persistent incomplete biochemical response in February-2017, a\n                      <jats:sup>18<\/jats:sup>\n                      Fluor-dexosiglucose positron emission computed tomography (FDG-PET) was performed. FDG-PET showed an intense pathological deposit in the right adrenal, suggestive of malignancy. Right adrenalectomy was carried out, and pathology revealed an Adrenocortical carcinoma (ACC). Genetic syndromes associated to ACC are: Li-Fraumeni syndrome (caused by an autosomal mutation in the TP53 gene), the Multiple Endocrine Neoplasia (MEN) type 1 (caused by\n                      <jats:italic>Menin<\/jats:italic>\n                      gene mutations), and MEN type 4 (caused by heterozygous mutations in the\n                      <jats:italic>CDNK1B<\/jats:italic>\n                      gene). However, none of them are associated to PTC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2020-0080_abs_004_w2aab3b7c51b1b6b1aab1c16b3Aa\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>To our knowledge this is the sixth published case reporting an ACC in presence of a PTC. The pathological factors behind the relation between these malignancies have not been elucidated. We do not discard the possibility of a genetic relationship between PTC and ACC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2020-0080","type":"journal-article","created":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:29:31Z","timestamp":1614990571000},"page":"199-201","source":"Crossref","is-referenced-by-count":1,"title":["A rare association of two endocrine tumours: non-functional oncocytic adrenocortical carcinoma and Papillary thyroid carcinoma"],"prefix":"10.1515","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-9354","authenticated-orcid":false,"given":"Jorge Gabriel","family":"Ruiz-S\u00e1nchez","sequence":"first","affiliation":[{"name":"Servicio de Endocrinolog\u00eda y Nutrici\u00f3n , Hospital Cl\u00ednico San Carlos, Instituto de Investigaci\u00f3n Sanitaria San Carlos (IdISSC) , Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0310-7095","authenticated-orcid":false,"given":"Paola","family":"Parra Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Servicio de Endocrinolog\u00eda y Nutrici\u00f3n , Hospital Universitario La Paz , Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Lisbona Catal\u00e1n","sequence":"additional","affiliation":[{"name":"Servicio de Endocrinolog\u00eda y Nutrici\u00f3n , Hospital Universitario La Paz , Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Carling, T, Udelsman, R. Thyroid cancer. Annu Rev Med 2014;65:125\u201337. https:\/\/doi.org\/10.1146\/annurev-med-061512-105739.","key":"2025121207185834155_j_hmbci-2020-0080_ref_001_w2aab3b7c51b1b6b1ab2b1b1Aa","DOI":"10.1146\/annurev-med-061512-105739"},{"doi-asserted-by":"crossref","unstructured":"Fassnacht, M, Dekkers, OM, Else, T, Baudin, E, Berruti, A, De Krijger, RR, et al.. European Society of Endocrinology. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 2018;179:G1-46. https:\/\/doi.org\/10.1530\/EJE-18-0608.","key":"2025121207185834155_j_hmbci-2020-0080_ref_002_w2aab3b7c51b1b6b1ab2b1b2Aa","DOI":"10.1530\/EJE-18-0608"},{"doi-asserted-by":"crossref","unstructured":"Lam, AK. Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocr Pathol 2017;28:213\u201327. https:\/\/doi.org\/10.1007\/s12022-017-9484-5.","key":"2025121207185834155_j_hmbci-2020-0080_ref_003_w2aab3b7c51b1b6b1ab2b1b3Aa","DOI":"10.1007\/s12022-017-9484-5"},{"doi-asserted-by":"crossref","unstructured":"Guha, T, Malkin, D. Inherited TP53 mutations and the Li\u2013Fraumeni syndrome. Cold Spring Harb Perspect Med 2017;7:a026187. https:\/\/doi.org\/10.1101\/cshperspect.a026187.","key":"2025121207185834155_j_hmbci-2020-0080_ref_004_w2aab3b7c51b1b6b1ab2b1b4Aa","DOI":"10.1101\/cshperspect.a026187"},{"doi-asserted-by":"crossref","unstructured":"Thakker, RV. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol 2014;386:2\u201315. https:\/\/doi.org\/10.1016\/j.mce.2013.08.002.","key":"2025121207185834155_j_hmbci-2020-0080_ref_005_w2aab3b7c51b1b6b1ab2b1b5Aa","DOI":"10.1016\/j.mce.2013.08.002"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2020-0080\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2020-0080\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:12:10Z","timestamp":1765527130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2020-0080\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":5,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,1,27]]},"published-print":{"date-parts":[[2021,7,20]]}},"alternative-id":["10.1515\/hmbci-2020-0080"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2020-0080","relation":{},"ISSN":["1868-1891","1868-1883"],"issn-type":[{"type":"electronic","value":"1868-1891"},{"type":"print","value":"1868-1883"}],"subject":[],"published":{"date-parts":[[2021,3,8]]}}}